![Kee-Hong Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kee-Hong Kim
Chief Tech/Sci/R&D Officer at
TENAYA THERAPEUTICS, INC.
Profile
Kee-Hong Kim is currently Chief Technology Officer at Tenaya Therapeutics, Inc. since 2018.
Former positions include Director-Process Development at Adverum Biotechnologies, Inc. from 2013 to 2015, Senior Vice President-Technical Operations at PTC Therapeutics GT, Inc. from 2017 to 2018, and Head-Gene Therapy Process at Shire, Inc. Education includes a doctorate from Colorado State University.
Kee-Hong Kim active positions
| Companies | Position | Start |
|---|---|---|
| TENAYA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2018-09-30 |
Former positions of Kee-Hong Kim
| Companies | Position | End |
|---|---|---|
PTC Therapeutics GT, Inc.
 PTC Therapeutics GT, Inc. Medical SpecialtiesHealth Technology Innovates DNA therapeutics, provides long-term efficacy for patients with debilitating & fata diseases | Chief Tech/Sci/R&D Officer | 2018-07-31 |
| ADVERUM BIOTECHNOLOGIES, INC. | Corporate Officer/Principal | 2015-03-31 |
Shire, Inc.
 Shire, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Corporate Officer/Principal | - |
Training of Kee-Hong Kim
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
33
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Colorado State University
 Colorado State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops gene therapies | Health Technology |
Shire, Inc.
Shire, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
PTC Therapeutics GT, Inc.
PTC Therapeutics GT, Inc. Medical SpecialtiesHealth Technology Innovates DNA therapeutics, provides long-term efficacy for patients with debilitating & fata diseases | Health Technology |
Tenaya Therapeutics, Inc.
 Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
- Stock Market
- Insiders
- Kee-Hong Kim
